FIELD: chemistry, pharmaceutics.
SUBSTANCE: invention relates to immunology. Described is tripeptide-L-Tyrosyl-L-Seryl-L-Valine and its application in pharmaceutical composition and in production of food additive. Discovered is method of relieving state of human disease, where disease is selected from group, which consists of states which can be relieved by stimulation of T-lymphocytes transformation, and fault of cell proliferation, which includes introduction of described pharmaceutical composition. Claimed invention gives short peptides which possess biological activity.
EFFECT: obtaining short peptides which possess biological activity.
8 cl, 5 dwg, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
BIOLOGICALLY ACTIVE DERIVATIVES OF PEPTIDE VAPEEHPTLLTEAPLNPK | 2005 |
|
RU2377249C2 |
GENE (LBFL313) FAMILY ASSOCIATED WITH MALIGNANT GROWTH OF PANCREAS | 2007 |
|
RU2432399C2 |
SPARC-BINDING PEPTIDES AND USING THEM | 2009 |
|
RU2491085C2 |
MODIFIED PROTEINS, CONSTRUCTED TOXINS AND METHODS FOR PRODUCTION THEREOF | 2002 |
|
RU2305684C2 |
POLYPEPTIDES OF DIRECTED ACTION | 2006 |
|
RU2393874C2 |
VACCINE COMPOSITIONS AND METHODS OF USE THEREOF | 2010 |
|
RU2600798C2 |
HUMANISED ANTIBODIES AGAINST CD79b AND IMMUNOCONJUGATES AND METHODS OF APPLICATION | 2008 |
|
RU2557319C2 |
METHOD OF TUMOUR TREATMENT IN SUBJECT | 2006 |
|
RU2404193C2 |
METHODS FOR TREATING MALIGNANT TUMOUR WITH APPLICATION OF NOTCH SIGNAL TRANSDUCTION PATHWAY INHIBITORS | 2008 |
|
RU2584579C2 |
METHODS AND COMPOSITIONS FOR ACTIVATION MODULATION OF HEPATOCYTE GROWTH FACTOR | 2005 |
|
RU2405041C2 |
Authors
Dates
2008-11-10—Published
2004-06-22—Filed